1-3 of 3
Fengting Liu, MD Ph.D
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tocilizumab Overcomes Chemo-Resistance Of CLL Cells

Fengting Liu, MD Ph.D, Li Jia, PhD, MD, Ping Wang, MD, Tim Farren, PhD, Samir G Agrawal, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5305.
https://doi.org/10.1182/blood.V122.21.5305.5305
Published: 2013
Journal Articles

Combined ROR1 and CD160 Detection For Improved Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia (CLL)

Timothy W. Farren, Ph.D, Fengting Liu, MD Ph.D, Marion G. Macey, Ph.D, Thomas J. Kipps, MD, PhD, Noel Warner, Samir G. Agrawal
Journal: Blood
Blood (2013) 122 (21): 2572.
https://doi.org/10.1182/blood.V122.21.2572.2572
Published: 2013
Journal Articles

Both PI3K p110α and p110δ Isoforms Control CD160-Mediated CLL Cell Viability and Cytokine Production

Timothy W. Farren, Ph.D, Fengting Liu, MD Ph.D, Samir G. Agrawal
Journal: Blood
Blood (2013) 122 (21): 4124.
https://doi.org/10.1182/blood.V122.21.4124.4124
Published: 2013